B-lymphoid tyrosine kinase (Blk) is an oncogene and a potential target for therapy with Dasatinib in cutaneous T-cell lymphoma (CTCL)

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt